Magnusiomyces Capitatus : A Rare Cause of Pneumonia

  • Remzi Bahşi Ankara University Faculty of Medicine, Department of Geriatrics
  • Ebru Evren Ankara University Faculty of Medicine, Department of Microbiology
  • Deniz Mut Sürmeli Ankara University Faculty of Medicine, Department of Geriatrics
  • Tuğba Turgut Ankara University Faculty of Medicine, Department of Geriatrics
  • Hande Selvi Öztorun Ankara University Faculty of Medicine, Department of Geriatrics
  • Ebru Us Ankara University Faculty of Medicine, Department of Microbiology
  • Zeynep Ceren Karahan Ankara University Faculty of Medicine, Department of Microbiology

Abstract

Introduction Pneumonia is an important cause of morbidity and mortality in elderly patients. Magnusiomyces should be kept in mind as a rare cause of pneumonia, because of high mortality rates (>%50). Case Presentation A 93-year-old male patient was admitted with cough, sputum, confusion and elevated inflamatuar markers and diagnosed with pneumonia. Magnusiomyces capitatus was detected in tracheal aspirate culture and detection of galactomannan antigen in tracheal aspirate fluid supported the diagnosis. After 10 days of intravenous Amphotericin B therapy pneumonia was improved. Conclusion Although it has been previously reported in the pleural fluid, we found it in tracheal aspirate culture. Because of its high mortality rates we recommend that clinicians should take this agent into account.

References

Lopardo G, Basombrío A, Clara L, et al Guidelines for management of community-acquired pneumonia in adults. Medicina (B Aires). 2015;75(4):245-57.

Sreeja S, Banashankari GS, Bhavana MV, et al. Blastoschizomyces capitatus pneumonia: a rare case. Indian J Pathol Microbiol. 2011;54(4):846-7.

Romano A, Giordano S, Di Carlo P, et al. Pulmonary infection caused by Blastoschizomices capitatus. Infez Med. 2005;13(3):187-91.

Brunetti G, Visconti V, Ghezzi MC, et al Management and treatment of Magnusiomyces capitatus (Geotrichum capitatum) pleural infection in a non-neutropenic patient with posaconazole. A new therapeutic opportunity? New Microbiol. 2016;39(4):307-9.

Published
2019-12-21